What are the non‑thrombocytopenic causes of purpura?

Non-Thrombocytopenic Causes of Purpura

The most common non-thrombocytopenic cause of purpura is small vessel vasculitis, particularly IgA vasculitis (formerly Henoch-Schönlein purpura), which presents as palpable purpura and accounts for approximately 59% of cases in adults 1.

Primary Categories of Non-Thrombocytopenic Purpura

1. Vasculitic Causes (Most Common)

The key distinguishing feature is palpable purpura - raised, non-blanching lesions that you can feel with your fingertips, indicating inflammation of vessel walls rather than simple platelet deficiency.

IgA Vasculitis (Henoch-Schönlein Purpura)

• Most common vasculitis causing purpura in both children and adults 1, 2
• Characterized by nonthrombocytopenic palpable purpura, arthritis, and abdominal pain 2
• Skin biopsy shows perivascular IgA deposits 3
• Spontaneously resolves in 94% of children and 89% of adults 2

Cutaneous Leukocytoclastic Vasculitis (CLV)

• Second most common cause, accounting for 23.5% of palpable purpura cases 1
• Often idiopathic and self-limited 4

ANCA-Associated Vasculitis

• Less common, representing only 3.5% of palpable purpura cases 1
• More serious systemic implications requiring aggressive treatment

2. Drug-Induced Purpura

Medications can cause non-thrombocytopenic purpura through cutaneous vasculitis mechanisms:

• Calcium channel blockers (nifedipine, diltiazem) are documented causes 5
• Important caveat: If purpura develops with one calcium channel blocker, avoid switching to another in the same class as cross-reactivity occurs 5
• Various other drugs can trigger vasculitic purpura 4

3. Infection-Related Purpura

• Viral infections (hepatitis C, HIV) can trigger secondary vasculitis
• Often preceded by recent viral illness, particularly in children 2

4. Rheumatologic Disease-Associated Vasculitis

• Accounts for 7.1% of palpable purpura cases 1
• Includes antiphospholipid antibody syndrome and other autoimmune conditions
• May represent manifestation of underlying systemic disease

5. Non-Vasculitic Causes

Approximately 7% of patients presenting with purpura have biopsy results not compatible with vasculitis 1, including:

• Embolic phenomena
• Coagulation disorders (with normal platelet counts)
• Vascular fragility syndromes
• Trauma

Clinical Approach Algorithm

Step 1: Confirm Normal Platelet Count

• Verify platelet count >100-150 × 10⁹/L to exclude thrombocytopenic causes

Step 2: Assess Purpura Characteristics

• Palpable purpura → Think vasculitis (most likely IgA vasculitis or CLV)
• Non-palpable purpura → Consider coagulopathy, vascular fragility, or embolic causes

Step 3: Identify Precipitating Factors

• Recent medication changes (especially calcium channel blockers, antibiotics)
• Recent viral illness (particularly in children)
• Known autoimmune disease
• Systemic symptoms (fever, joint pain, abdominal pain, hematuria)

Step 4: Determine Need for Skin Biopsy

• Indicated when cause unclear from history/examination 4
• Helps differentiate vasculitic from non-vasculitic causes
• Shows IgA deposits in IgA vasculitis 3

Critical Pitfalls to Avoid

1. Don't assume all purpura is thrombocytopenic - Always check platelet count, but recognize that normal platelets with purpura indicates a different pathophysiology requiring different management

2. Don't miss drug-induced vasculitis - Carefully review all medications, including over-the-counter drugs and recent additions 5

3. Don't switch between calcium channel blockers if one caused purpura - cross-reactivity is documented 5

4. Don't use prophylactic steroids in IgA vasculitis - They do not prevent complications and should be reserved for treating established glomerulonephritis or other serious complications 2

5. Don't forget long-term renal monitoring - Even after resolution, IgA vasculitis can relapse years later; minimum 6 months follow-up is prudent 2

Treatment Considerations

When treatment is necessary beyond supportive care:

• Dapsone, colchicine, or systemic corticosteroids are useful for idiopathic cases 4
• High-dose steroids, cyclosporine, or mycophenolate for IgA vasculitis with glomerulonephritis 2
• Drug discontinuation is curative for drug-induced cases 5

The evidence strongly indicates that most non-thrombocytopenic purpura represents small vessel vasculitis, with IgA vasculitis being the predominant cause requiring recognition and appropriate monitoring for renal complications.